Grace Johnston

Analytic framework for clinician provision of end-of-life care.

Trends in the place of death of cancer patients, 1992-1997.

Family physician continuity of care and emergency department use in end-of-life cancer care.

Evolution of interprofessional learning: Dalhousie University's "From Family Violence to Health" module.

Primary care continuity and location of death for those with cancer.

Community-based cultural predictors of Pap smear screening in Nova Scotia.

Radiotherapy wait times for patients with a diagnosis of invasive cancer, 1992-2000.

Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction.

Health care restructuring and family physician care for those who died of cancer.

Home visits by family physicians during the end-of-life: Does patient income or residence play a role?

Where a cancer patient dies: the effect of rural residency.

Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor.

Alleviation of thermoregulatory dysfunction with the new serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized rodent models.

Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodology.

End-of-life care for nursing home residents dying from cancer in Nova Scotia, Canada, 2000-2003.

Subchronic 17alpha-ethinyl estradiol differentially affects subtypes of sleep and wakefulness in ovariectomized rats.

Toward population-based indicators of quality end-of-life care: testing stakeholder agreement.

Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.

Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.

Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.

A population-based study of age inequalities in access to palliative care among cancer patients.

3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.

Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.

Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.

1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.

Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.

Variation in the use of palliative radiotherapy at end of life: examining demographic, clinical, health service, and geographic factors in a population-based study.

Exploring generalizability in a study of costs for community-based palliative care.

Perspectives of an interdisciplinaryg research team to engage practice: lessons from a knowledge exchange trainee experience.

Preventive medication use among persons with limited life expectancy.

Identifying population groups with low palliative care program enrolment using classification and regression tree analysis.

The effect of an educational intervention on meperidine use in Nova Scotia, Canada: a time series analysis.

Impact of comorbidity and healthcare utilization on colorectal cancer stage at diagnosis: literature review.